We are live on ! Find out more

Drug Manufacturers - General
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
XTNT icon
26
Xtant Medical Holdings
XTNT
$45M
$45M $0.3210 0.16%
NSRX
27
Nasus Pharma
NSRX
$42.5M
$42.5M $3.63 3.97%
CPHI icon
28
China Pharma Holdings
CPHI
$41.3M
$41.3M $0.9600 12.9%
IBO
29
Impact BioMedical
IBO
$35.1M
$35.1M $4.11 8.26%
CVM icon
30
CEL-SCI Corp
CVM
$34.3M
$34.3M $1.95 8.45%
ATNM icon
31
Actinium Pharmaceuticals
ATNM
$34M
$34M $1.08 0.93%
NNVC icon
32
NanoViricides
NNVC
$33.4M
$33.4M $1.31 9.03%
MIRA icon
33
MIRA Pharmaceuticals
MIRA
$29.5M
$29.5M $0.7030 0.99%
IGC icon
34
IGC Pharma
IGC
$29.5M
$29.5M $0.2849 1.75%
SCLX icon
35
Scilex Holding
SCLX
$20.8M
$20.8M $2.96 15.2%
AEON icon
36
AEON Biopharma
AEON
$15.5M
$15.5M $0.3100 0.42%
RGNT
37
Regentis Biomaterials
RGNT
$11.9M
$11.9M $1.70 4.29%
TOVX icon
38
Theriva Biologics
TOVX
$10.4M
$10.4M $0.2271 2.95%
APUS
39
Apimeds Pharmaceuticals US
APUS
$8.32M
$8.32M $5.51 21.8%
AZTR icon
40
Azitra
AZTR
$8M
$8M $0.1320 0%
MDCX
41
Medicus Pharma
MDCX
$7.31M
$7.31M $0.1019 36.4%
AIM
42
AIM ImmunoTech
AIM
$7.17M
$7.17M $0.1796 1.75%
CANF
43
Can-Fite BioPharma American Depositary Shares
CANF
$4.29M
$4.29M $2 4.76%
KAPA
44
Kairos Pharma
KAPA
$3.25M
$3.25M $0.9595 10.3%
MTNB icon
45
Matinas BioPharma
MTNB
$2.77M
$2.77M $2.83 2.17%
CLDI icon
46
Calidi Biotherapeutics
CLDI
$2.69M
$2.69M $1.04 2.97%
HLSQ
47
Tessera Defense and Homeland Security Inc.
HLSQ
$2.63M
$2.63M $0.2915 5.72%
OGEN icon
48
Oragenics
OGEN
$2.09M
$2.09M $0.4630 7.38%
1
2

Drug Manufacturers - General Stocks at a Glance

Large drug manufacturers sell diversified portfolios of branded medicines backed by deep development pipelines. Patent lives set the clock: blockbuster franchises fund the R&D and acquisitions needed to outrun expirations, supporting durable margins and dividends.

There are 48 Drug Manufacturers - General industry stocks tracked by Wall St. Rank, worth a combined $4.1T.

The largest by market cap are Eli Lilly (LLY) at $1.04T, Johnson & Johnson (JNJ) at $618B and AbbVie (ABBV) at $481B.

Among institutional investors, Eli Lilly (LLY) drew the most net new fund positions in Q2 2026: 417 funds opened new positions, taking total fund holders up 253 (5.8%) quarter-over-quarter.

  • Combined market cap: $4.1T across 48 stocks.
  • Largest constituent: Eli Lilly (LLY), $1.04T market cap.
  • Most net new fund positions in Q2 2026: Eli Lilly (LLY), +253 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.